Cargando…
An engineered activated factor V for the prevention and treatment of acute traumatic coagulopathy and bleeding in mice
Acute traumatic coagulopathy (ATC) occurs in approximately 30% of patients with trauma and is associated with increased mortality. Excessive generation of activated protein C (APC) and hyperfibrinolysis are believed to be driving forces for ATC. Two mouse models were used to investigate whether an e...
Autores principales: | Joseph, Bilgimol Chumappumkal, Miyazawa, Byron Y., Esmon, Charles T., Cohen, Mitchell J., von Drygalski, Annette, Mosnier, Laurent O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Hematology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945312/ https://www.ncbi.nlm.nih.gov/pubmed/34861695 http://dx.doi.org/10.1182/bloodadvances.2021005257 |
Ejemplares similares
-
COVID-19 coagulopathy, thrombosis, and bleeding
por: Chan, Noel C., et al.
Publicado: (2020) -
Blocking human protein C anticoagulant activity improves clotting defects of hemophilia mice expressing human protein C
por: Jiang, Miao, et al.
Publicado: (2022) -
The bleeding phenotype in people with nonsevere hemophilia
por: Kloosterman, Fabienne R., et al.
Publicado: (2022) -
Selective modulation of activated protein C activities by a nonactive site–targeting nanobody library
por: Sim, Derek S., et al.
Publicado: (2023) -
Whole-exome analysis of adolescents with low VWF and heavy menstrual bleeding identifies novel genetic associations
por: Sadler, Brooke, et al.
Publicado: (2022)